05 Apr 2023 21:23 CEST

Issuer

Aqua Bio Technology ASA

5.4.2023 21:23:57 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

Aqua Bio Technology ASA ("ABT" or the "Company") has received a letter with
claims for compensations from an employee who is under termination.

The Employee has been issued a notice of termination from the Company due to
circumstances associated with the business operations. The person concerned has
disputed the validity of the dismissal and put forward a claim for compensation.
ABT maintains that the termination is lawful and intends to deny the claim.

Concurrently, the same Employee has presented a claim for compensation from the
Company, estimated to approximately NOK 12 million related to transfer of shares
in ABT. The Company's understanding is that there was an intention for the main
shareholders to transfer shares to a holding company controlled by the employer;
however, this plan was not implemented due to disagreements between the
principal shareholders and the Employee's holding company on the terms for such
a transfer. ABT is of the view that this dispute is a matter between the main
shareholders and the holding company under the Employee's control, and that this
discord bears no relevance to the relationship between ABT and the Employee. ABT
also plans to reject the compensation claim related to the shares.

****

For further information, please contact Håvard Lindstrøm, CEO, telephone +47
941 32 288.

This information is subject to the disclosure requirements in Regulation EU
596/2014 article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Euronext Expand.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/2239/3062/Download%20announcement
%20as%20PDF.pdf


587246_Download announcement as PDF.pdf

Source

Aqua Bio Technology ASA

Provider

Oslo Børs Newspoint

Company Name

AQUA BIO TECHNOLOGY

ISIN

NO0010307135

Symbol

ABTEC

Market

Euronext Expand